Literature DB >> 29167807

Nicotinamide: a novel treatment for age-related macular degeneration?

Peter D Westenskow1.   

Abstract

Entities:  

Year:  2017        PMID： 29167807      PMCID： PMC5676191          DOI： 10.21037/sci.2017.10.01

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


× No keyword cloud information.
  32 in total

1.  Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression.

Authors:  Chuan-Ming Li; Mark E Clark; Melissa F Chimento; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

Review 2.  Recent developments in the treatment of age-related macular degeneration.

Authors:  Frank G Holz; Steffen Schmitz-Valckenberg; Monika Fleckenstein
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

Review 3.  Mechanisms of photoreceptor death and survival in mammalian retina.

Authors:  J Stone; J Maslim; K Valter-Kocsi; K Mervin; F Bowers; Y Chu; N Barnett; J Provis; G Lewis; S K Fisher; S Bisti; C Gargini; L Cervetto; S Merin; J Peér
Journal:  Prog Retin Eye Res       Date:  1999-11       Impact factor: 21.198

4.  Targeted deletion of Vegfa in adult mice induces vision loss.

Authors:  Toshihide Kurihara; Peter D Westenskow; Stephen Bravo; Edith Aguilar; Martin Friedlander
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

5.  Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Authors:  Kim N Green; Joan S Steffan; Hilda Martinez-Coria; Xuemin Sun; Steven S Schreiber; Leslie Michels Thompson; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

6.  Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.

Authors:  Swaantje Peters; Peter Heiduschka; Sylvie Julien; Focke Ziemssen; Heike Fietz; Karl Ulrich Bartz-Schmidt; Ulrich Schraermeyer
Journal:  Am J Ophthalmol       Date:  2007-04-23       Impact factor: 5.258

7.  Functional analysis of serially expanded human iPS cell-derived RPE cultures.

Authors:  Ruchira Singh; M Joseph Phillips; David Kuai; Jackelyn Meyer; Jessica M Martin; Molly A Smith; Enio T Perez; Wei Shen; Kyle A Wallace; Elizabeth E Capowski; Lynda S Wright; David M Gamm
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-17       Impact factor: 4.799

8.  Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa.

Authors:  Claudio Punzo; Karl Kornacker; Constance L Cepko
Journal:  Nat Neurosci       Date:  2008-12-07       Impact factor: 24.884

Review 9.  Dementia of the eye: the role of amyloid beta in retinal degeneration.

Authors:  J A Ratnayaka; L C Serpell; A J Lotery
Journal:  Eye (Lond)       Date:  2015-06-19       Impact factor: 3.775

10.  VEGF regulates local inhibitory complement proteins in the eye and kidney.

Authors:  Lindsay S Keir; Rachel Firth; Lyndsey Aponik; Daniel Feitelberg; Susumu Sakimoto; Edith Aguilar; Gavin I Welsh; Anna Richards; Yoshihiko Usui; Simon C Satchell; Valeryia Kuzmuk; Richard J Coward; Jonathan Goult; Katherine R Bull; Ruchi Sharma; Kapil Bharti; Peter D Westenskow; Iacovos P Michael; Moin A Saleem; Martin Friedlander
Journal:  J Clin Invest       Date:  2016-12-05       Impact factor: 14.808
View more
  2 in total

1.  Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury.

Authors:  Deokho Lee; Yohei Tomita; Yukihiro Miwa; Ari Shinojima; Norimitsu Ban; Shintaro Yamaguchi; Ken Nishioka; Kazuno Negishi; Jun Yoshino; Toshihide Kurihara
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

Review 2.  Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration.

Authors:  Gloria Cimaglia; Marcela Votruba; James E Morgan; Helder André; Pete A Williams
Journal:  Nutrients       Date:  2020-09-19       Impact factor: 5.717
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.